ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,557Medicare Part D Prescriptions Filled, Including Refills

Rank: 463 out of 1456

$465K Total Retail Price of All Prescriptions

Rank: 486 out of 1456

292 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 292 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,951 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 465 367 1 1
NAMENDA 256 239 2 38
PRAVASTATIN SODIUM 250 161 3 9
METOPROLOL TARTRATE 245 162 4 12
CITALOPRAM HBR 230 169 5 22
LISINOPRIL 206 144 6 3
DONEPEZIL HCL 189 186 7 29
DIVALPROEX SODIUM 188 145 8 108
TRAZODONE HCL 170 106 9 47
LEVOTHYROXINE SODIUM 160 129 10 4
HYDROCODONE-ACETAMINOPHEN 149 116 S3 11 6
METFORMIN HCL 147 102 12 8
OMEPRAZOLE 146 100 13 5
FUROSEMIDE 139 126 14 7
GABAPENTIN 125 56 15 13
LANTUS 125 96 15 50
RISPERIDONE 123 66 17 72
LEVETIRACETAM 120 68 18 97
SANTYL 104 74 19 226
CARVEDILOL 103 84 20 20
QUETIAPINE FUMARATE 100 67 21 78
NOVOLOG 95 68 22 104
ATENOLOL 93 62 23 18
ALENDRONATE SODIUM 91 75 24 36
DIOVAN 87 43 25 35
HYDROCHLOROTHIAZIDE 84 38 26 10
EXELON 79 70 27 105
MIRTAZAPINE 78 65 28 65
DIGOXIN 75 51 29 62
CYMBALTA 74 39 30 52
CLONIDINE HCL 69 39 31 39
SIMVASTATIN 66 37 32 2
TAMSULOSIN HCL 66 42 32 34
SERTRALINE HCL 64 58 34 25
POTASSIUM CHLORIDE 64 61 34 15
OXYCODONE-ACETAMINOPHEN 63 40 S2 36 109
HYDRALAZINE HCL 62 37 37 48
METOCLOPRAMIDE HCL 62 34 37 125
WARFARIN SODIUM 60 35 39 21
NAPROXEN 60 46 39 100
CLOPIDOGREL 58 46 41 32
ZOLPIDEM TARTRATE 57 22 42 14
OLANZAPINE 57 26 42 183
OXYBUTYNIN CHLORIDE 56 53 44 156
FLUOXETINE HCL 55 42 45 55
PREDNISONE 55 33 45 42
NOVOLIN R 54 47 47 133
ESCITALOPRAM OXALATE 50 44 48 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.